Anamaria Bancos

Cluj-napoca, CJ, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Integrating Flow Cytometry in the Diagnostic Work of HIV-Associated Hodgkin's Lymphomas.

Integrating Flow Cytometry in the Diagnostic Work of HIV-Associated Hodgkin's Lymphomas.

Journal: Journal of cellular and molecular medicine

Published: February 18, 2026

Integrating venetoclax-based targeted and/or immune therapies for chronic lymphocytic leukemia.

Integrating venetoclax-based targeted and/or immune therapies for chronic lymphocytic leukemia.

Journal: Critical reviews in oncology/hematology

Published: December 14, 2025

The crosstalk between epigenetics and metabolism in the malignant cell.

The crosstalk between epigenetics and metabolism in the malignant cell.

Journal: Discover oncology

Published: December 10, 2025

Patient-centered and coordinated therapy with RNA interference-based givosiran for acute hepatic porphyria: real-life experience for an ultra-rare disease from Romania.

Patient-centered and coordinated therapy with RNA interference-based givosiran for acute hepatic porphyria: real-life experience for an ultra-rare disease from Romania.

Journal: Blood science (Baltimore, Md.)

Published: September 23, 2025

Real-world patient outcomes with Blinatumomab and Inotuzumab in adult relapsed/refractory B-cell acute lymphoblastic leukemia: a retrospective analysis from two Romanian oncology centers.

Real-world patient outcomes with Blinatumomab and Inotuzumab in adult relapsed/refractory B-cell acute lymphoblastic leukemia: a retrospective analysis from two Romanian oncology centers.

Journal: Frontiers in pharmacology

Published: August 12, 2025

Snapshot Look at Castleman Disease.

Snapshot Look at Castleman Disease.

Journal: Journal of cellular and molecular medicine

Published: August 11, 2025

CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases.

CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases.

Journal: Blood reviews

Published: July 23, 2025

Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies.

Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies.

Journal: Biomarker research

Published: July 16, 2025

Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma.

Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma.

Journal: Biomarker research

Published: May 02, 2025

Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies.

Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies.

Journal: Cell death discovery

Published: March 08, 2025

Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience.

Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience.

Journal: Journal of hematology

Published: September 02, 2024

"Lazarus Response" When Feto-Maternal Microchimerism Kicks in: Spontaneous Remission in Refractory Primary Mediastinal B Cell Lymphoma Following Twin Pregnancy.

"Lazarus Response" When Feto-Maternal Microchimerism Kicks in: Spontaneous Remission in Refractory Primary Mediastinal B Cell Lymphoma Following Twin Pregnancy.

Journal: Diagnostics (Basel, Switzerland)

Published: August 05, 2024

Showing 1-12 of 17

Last Updated: 09/26/2026